Marjorie Sennett
Net worth: 2 M $ as of 29/06/2026
Net worth: 2 M $ as of 29/06/2026
Marjorie T.
Sennett is currently an Independent Director at Cognex Corp.
since 2021 and an Independent Director at Visteon Corp.
starting in 2025.
Formerly, the roles include Managing Director at Farallon Capital Management LLC from 2002 to 2009, Independent Director at QuinStreet, Inc. from 2014 to 2018, Director at The diaTribe Foundation from 2017 to 2025, Chief Financial Officer & Senior Vice President at Amylin Pharmaceuticals, Inc. from 1997 to 1998, Chief Financial Officer & Senior Vice President at eGroups, Inc. from 1999 to 2000, and Assistant Treasurer & Associate at Bankers Trust Corp.
in 1986.
Education includes an undergraduate degree from Vanderbilt University conferred in 1982 and an MBA from Stanford Graduate School of Business conferred in 1988.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
COGNEX CORPORATION 0.02% | 26/02/2026 | 25,936 ( 0.02% ) | 2 M $ | 29/06/2026 |
| 16/07/2026 | 1,219 ( 0% ) | 120 937 $ | 29/06/2026 |
| Companies | Position | Start |
|---|---|---|
| COGNEX CORPORATION | Director/Board Member | 02/11/2021 |
| VISTEON CORPORATION | Director/Board Member | 17/07/2025 |
| Companies | Position | End |
|---|---|---|
Diatribe Foundation
Diatribe Foundation Miscellaneous Commercial ServicesCommercial Services The Diatribe Foundation is a nonprofit organization dedicated to improving the lives of people with diabetes and prediabetes through education, advocacy, and community engagement. The private company is based in San Francisco. The foundation provides patient-centered, actionable information to enhance health and quality of life, including resources on all major types of diabetes, management strategies, medications, and emerging technologies. Key initiatives include the online publication Diatribe Learn, the Time in Range Coalition to promote accessible diabetes metrics, and the dStigmatize program to combat diabetes stigma. The organization emphasizes mental health, offers practical guidance on lifestyle management, and highlights clinical research and advances in diabetes technology. | Director/Board Member | 31/12/2024 |
| QUINSTREET, INC. | Director/Board Member | 31/12/2017 |
Farallon Capital Management LLC
Farallon Capital Management LLC Investment ManagersFinance Farallon seeks investments across asset classes and around the world through a process of bottom-up fundamental research and analysis emphasizing capital preservation. Their investment strategies include Credit Investments, Long/Short Equity, Merger Arbitrage, Risk Arbitrage, Real Estate Investments and Direct Investments. Investment ideas compete for capital based on in-depth, critical assessment of specific risks and rewards. Risk is monitored and managed through rigorous and thorough analysis of each investment and, at the portfolio level, through risk management analytics and overlay and tail-risk hedging. | Analyst-Equity | 30/12/2009 |
eGroups, Inc.
eGroups, Inc. Internet Software/ServicesTechnology Services Operates online portals that enables users to send and receive emails, schedule meetings, share files and photos | Director of Finance/CFO | 31/12/1999 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Director of Finance/CFO | 31/12/1997 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Cognex Corp.
Cognex Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and markets machine vision computer systems | Electronic Technology |
Farallon Capital Management LLC
Farallon Capital Management LLC Investment ManagersFinance Farallon seeks investments across asset classes and around the world through a process of bottom-up fundamental research and analysis emphasizing capital preservation. Their investment strategies include Credit Investments, Long/Short Equity, Merger Arbitrage, Risk Arbitrage, Real Estate Investments and Direct Investments. Investment ideas compete for capital based on in-depth, critical assessment of specific risks and rewards. Risk is monitored and managed through rigorous and thorough analysis of each investment and, at the portfolio level, through risk management analytics and overlay and tail-risk hedging. | Finance |
eGroups, Inc.
eGroups, Inc. Internet Software/ServicesTechnology Services Operates online portals that enables users to send and receive emails, schedule meetings, share files and photos | Technology Services |
Visteon Corp.
Visteon Corp. Auto Parts: OEMProducer Manufacturing Designs, manufactures and supplies instrument clusters, displays, infotainment, domain controllers and driver assistance systems | Producer Manufacturing |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
QuinStreet, Inc.
QuinStreet, Inc. Advertising/Marketing ServicesCommercial Services Provides online and offline marketing services | Commercial Services |
Bankers Trust Corp.
Bankers Trust Corp. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Stanford Graduate School of Business
Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Diatribe Foundation
Diatribe Foundation Miscellaneous Commercial ServicesCommercial Services The Diatribe Foundation is a nonprofit organization dedicated to improving the lives of people with diabetes and prediabetes through education, advocacy, and community engagement. The private company is based in San Francisco. The foundation provides patient-centered, actionable information to enhance health and quality of life, including resources on all major types of diabetes, management strategies, medications, and emerging technologies. Key initiatives include the online publication Diatribe Learn, the Time in Range Coalition to promote accessible diabetes metrics, and the dStigmatize program to combat diabetes stigma. The organization emphasizes mental health, offers practical guidance on lifestyle management, and highlights clinical research and advances in diabetes technology. | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions